ニューヨークにおけるユーイング肉腫の臨床試験
ニューヨーク内の拠点で、ユーイング肉腫に関する12件の研究が参加者を募集しています。
ニューヨーク内の都市
公式研究テキスト（英語）
Metastatic Ewing's Trial Testing Schedule Enhancement to Improve Outcomes
- Roswell Park Comprehensive Cancer Center, Buffalo
- Montefiore Medical Center, The Bronx
被験者募集中第1相
1歳以上 · 全性別 · 2026/09/25更新 · NCT07194044Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS)
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
2歳以上 · 全性別 · 2026/09/25更新 · NCT07297979Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Memorial Sloan Kettering Cancer Center ( Site 1010), New York
- New York Medical College ( Site 1023), Valhalla
被験者募集中第1/2相
6 Months – 25 Years · 全性別 · 2026/09/17更新 · NCT06395103Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
12歳〜85歳 · 全性別 · 2026/09/08更新 · NCT03715933Lurbinectedin in FET-Fused Tumors
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
10歳以上 · 全性別 · 2026/09/02更新 · NCT05918640Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
被験者募集中第1/2相
12 Months – 30 Years · 全性別 · 2026/08/25更新 · NCT04851119A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1相
16歳以上 · 全性別 · 2026/06/02更新 · NCT07197554Assessment of Healing and Function After Reconstruction Surgery for Bone Sarcomas
- Memorial Sloan Kettering Westchester (Consent and Followup), Harrison
- Memorial Sloan Kettering Cancer Center, New York
- Memorial Sloan Kettering at Nassau (Consent and Followup), Uniondale
被験者募集中観察研究
4歳以上 · 全性別 · 2026/04/17更新 · NCT03442465Vorinostat in Combination With Chemotherapy in Relapsed/Refractory Solid Tumors and CNS Malignancies
- New York Medical College, Valhalla
被験者募集中第1相
1歳〜30歳 · 全性別 · 2026/04/15更新 · NCT04308330Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
- Albert Einstein College of Medicine, Children's Hospital at Montefiore, The Bronx
- New York Medical Center/ Maria Fareri Children's Hospital, Valhalla
被験者募集中第2相
1歳〜50歳 · 全性別 · 2026/03/13更新 · NCT01804634Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma
- Memorial Sloan Kettering Cancer Center, New York
被験者募集中第1/2相
2歳〜30歳 · 全性別 · 2026/02/03更新 · NCT05734066A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital at Montefiore, The Bronx
被験者募集中第2相
18 Months – 40 Years · 全性別 · 2025/08/12更新 · NCT05135975ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。